MTHFD2L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.180600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.886000E-01
Normal-vs-Stage2
1.064590E-01
Normal-vs-Stage3
1.714360E-02
Normal-vs-Stage4
3.977200E-01
Stage1-vs-Stage2
7.738100E-02
Stage1-vs-Stage3
4.320400E-02
Stage1-vs-Stage4
1.572050E-01
Stage2-vs-Stage3
2.315600E-01
Stage2-vs-Stage4
2.574000E-01
Stage3-vs-Stage4
1.744450E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.430800E-01
Normal-vs-AfricanAmerican
8.621600E-01
Normal-vs-Asian
1.394580E-01
Caucasian-vs-AfricanAmerican
4.860600E-01
Caucasian-vs-Asian
5.920200E-01
AfricanAmerican-vs-Asian
4.693400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.679800E-01
Normal-vs-Female
5.033200E-01
Male-vs-Female
4.221600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.534800E-01
Normal-vs-Age(41-60Yrs)
5.719400E-01
Normal-vs-Age(61-80Yrs)
3.383000E-01
Normal-vs-Age(81-100Yrs)
1.369630E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.637220E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.494600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.025600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.147000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.266600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.718400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.515900E-02
Normal-vs-Daily Drinker
5.021200E-01
Normal-vs-Weekly Drinker
1.185690E-02
Normal-vs-Occasional Drinker
8.488800E-01
Normal-vs-Social Drinker
7.902600E-01
Non Drinker-vs-Daily Drinker
4.076800E-01
Non Drinker-vs-Weekly Drinker
2.525600E-01
Non Drinker-vs-Occasional Drinker
2.813800E-01
Non Drinker-vs-Social Drinker
1.651240E-01
Daily Drinker-vs-Weekly Drinker
1.231980E-01
Daily Drinker-vs-Occasional Drinker
5.836400E-01
Daily Drinker-vs-Social Drinker
5.094600E-01
Weekly Drinker-vs-Occasional Drinker
1.294830E-01
Weekly Drinker-vs-Social Drinker
5.612000E-02
Occasional Drinker-vs-Social Drinker
9.919400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.411380E-01
Normal-vs-Grade 2
2.418000E-02
Normal-vs-Grade 3
6.829700E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.895500E-02
Grade 1-vs-Grade 3
6.241700E-02
Grade 1-vs-Grade 4
1.411380E-01
Grade 2-vs-Grade 3
8.884000E-01
Grade 2-vs-Grade 4
2.418000E-02
Grade 3-vs-Grade 4
6.829700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.074000E-01
Normal-vs-NonDiabetic
4.288600E-01
Diabetic-vs-NonDiabetic
2.252600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.538400E-01
Normal-vs-NoPancreatitis
4.009000E-01
Pancreatitis-vs-NoPancreatitis
9.491800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.331200E-01
Normal-vs-N1
1.118840E-01
N0-vs-N1
2.054200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.806600E-01
Normal-vs-TP53-NonMutant
9.650800E-01
TP53-Mutant-vs-TP53-NonMutant
6.943100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
